(19)

(11)

EP 1 833 501 A1

(12)

(43) Date of publication: 19.09.2007 Bulletin 2007/38 (21) Application number: 05815992.2 (22) Date of filing: 01.12.2005

(51) International Patent Classification (IPC):  A61K 38/10(2006.01) A61P 35/02(2006.01) G01N 33/567(2006.01) (86) International application number: PCT/CA2005/001831 (87) International publication number: WO 2006/058431 (08.06.2006 Gazette 2006/23)

(84) Designated Contracting States: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR (30) Priority: 01.12.2004 CA 2488777 15.04.2005 CA 2502479 (71) Applicant: Ambrilia Biopharma Inc. Verdun, Quebec H3E 1H4 (CA)

(72) Inventors: ANNABI, Borhane Brossard, Québec J4Y 3B6 (CA) PANCHAL, Chandra, L. London, Ontario N6P 1E3 (CA) WU, Jinzi, Jason Dollard-des-Ormeaux, Québec H9A 3K3 (CA) BÉLIVEAU, Richard Montréal, Québec H3E 1L8 (CA) RUIZ, Marcia Ste-Geneviève, Québec H9H 1E4 (CA) GARDE, Seema Montréal, Québec H4B 1R8 (CA) BOUZEGHRANE, Mounia Montréal, Québec H1P 1S9 (CA) (74) Representative: Gardner, Rebecca Katherine  Frank B. Dehn & Co. St Bride's House 10 Salisbury Square London EC4Y 8JD London EC4Y 8JD (GB)